65,625 Shares in The Clorox Company $CLX Bought by Alps Advisors Inc.

Key Points

• Alps Advisors initiated a position in Clorox, buying 65,625 shares worth approximately $5.3 million, or about 0.05% of the company.
• Clorox reported quarterly EPS of $1.55, beating the $1.07 consensus, while revenue of $1.91 billion rose 33.3% year over year.
• The company announced a quarterly dividend of $1.25 per share, equivalent to a 5.0% annualized yield. Analysts’ consensus rating was “Reduce,” with a $93.79 average price target.

Alps Advisors Inc. purchased a new position in The Clorox Company (NYSE:CLX - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 65,625 shares of the company's stock, valued at approximately $5,316,000. Alps Advisors Inc. owned about 0.05% of Clorox as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the business. NewEdge Advisors LLC boosted its stake in Clorox by 11.8% during the 2nd quarter. NewEdge Advisors LLC now owns 75,135 shares of the company's stock valued at $7,171,000 after purchasing an additional 7,956 shares during the period. Public Employees Retirement System of Ohio acquired a new stake in shares of Clorox in the second quarter valued at approximately $3,277,000. Corient Private Wealth LP acquired a new stake in shares of Clorox in the second quarter valued at approximately $6,621,000. Allen Mooney & Barnes Investment Advisors LLC raised its holdings in shares of Clorox by 3,309.3% during the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 186,316 shares of the company's stock valued at $15,093,000 after buying an additional 180,851 shares during the last quarter. Finally, Bank of America Corp DE raised its holdings in shares of Clorox by 6.1% during the first quarter. Bank of America Corp DE now owns 1,405,774 shares of the company's stock valued at $145,680,000 after buying an additional 80,618 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Down 0.2%

Shares of NYSE CLX opened at $99.80 on Monday. The Clorox Company has a 12 month low of $79.12 and a 12 month high of $128.90. The company has a market cap of $12.09 billion, a price-to-earnings ratio of 17.95, a P/E/G ratio of 3.16 and a beta of 0.59. The company has a quick ratio of 0.39, a current ratio of 0.65 and a debt-to-equity ratio of 32.91. The business has a fifty day simple moving average of $87.71 and a 200-day simple moving average of $99.67.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.07 by $0.48. The company had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.88 billion. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The company's revenue for the quarter was up 33.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.85 earnings per share. Sell-side analysts predict that The Clorox Company will post 5.75 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Wednesday, October 28th. This represents a $5.00 dividend on an annualized basis and a yield of 5.0%. Clorox's payout ratio is presently 89.93%.

Insider Buying and Selling

In related news, Director Pierre Breber acquired 4,000 shares of the company's stock in a transaction on Wednesday, November 4th. The shares were purchased at an average price of $100.06 per share, for a total transaction of $400,240.00. Following the purchase, the director owned 22,000 shares in the company, valued at $2,201,320. This represents a 22.22% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.51% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CLX. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $95.00 price objective on shares of Clorox in a report on Monday, October 19th. UBS Group set a $88.00 target price on Clorox in a research note on Tuesday, November 3rd. Citigroup reduced their price target on Clorox from $97.00 to $90.00 and set a "neutral" rating for the company in a research report on Wednesday, October 14th. BNP Paribas Exane decreased their price target on Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research note on Monday, July 20th. Finally, Wall Street Zen raised Clorox from a "sell" rating to a "hold" rating in a report on Saturday. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Reduce" and a consensus target price of $93.79.

Clorox Company Profile

The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care.

Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt's Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.

Clorox serves consumers primarily in the United States and also sells products in international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.